Turtle Cameroninsider trades
In SEC Form 4 filings, Turtle Cameron is listed as Chief Executive Officer of Spyre Therapeutics, Inc. (SYRE). In the last 90 days, Turtle Cameron sold $2.69M of Spyre Therapeutics, Inc. (SYRE) on the open market and bought none. All 10 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| SYRESpyre Therapeutics, Inc. | Chief Executive Officer | 10 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | S | 600 | $89.14 | Sale −$53,484 | 551,940 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | S | 2,683 | $90.10 | Sale −$241,738 | 549,257 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | S | 2,638 | $91.49 | Sale −$241,351 | 546,619 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | S | 3,989 | $92.31 | Sale −$368,225 | 542,630 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | S | 4,990 | $93.37 | Sale −$465,916 | 537,640 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Oct 1 | Oct 2 | S | 100 | $93.91 | Sale −$9,391 | 537,540 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 1 | Sep 3 | S | 2,500 | $86.36 | Sale −$215,900 | 565,040 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 1 | Sep 3 | S | 8,400 | $87.15 | Sale −$732,060 | 556,640 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 1 | Sep 3 | S | 3,700 | $88.06 | Sale −$325,822 | 552,940 | Yes | Form 4 |
| SYRESpyre Therapeutics, Inc. | Sep 1 | Sep 3 | S | 400 | $89.07 | Sale −$35,628 | 552,540 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.